All News #Library
Rare Diseases
Two Rare Disease Focused Biotechs Raise $900 Million in Follow-on Offerings
02 Jul 2020 //
GLOBALNEWS
FDA Approves Celgene and Acceleron`s Treatment for Rare Blood Disease
09 Nov 2019 //
BIOSPACE

Market Place
Sourcing Support